SCHEMBL7565856

SCHEMBL7565856

CC(=O)OC(C)Nc1[c]cccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35
CYP3A4 P08684 1/20 0.35
MTNR1A P48039 5/20 0.33
MTNR1B P49286 5/20 0.33
TSHR P16473 4/20 0.33
LMNA P02545 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HDAC9 Q9UKV0 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33
GAA P10253 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7802302 0.78 TDP1 (0.30)
SCHEMBL7795576 0.75 MAPT (0.41) ALDH1A1MTNR1AMTNR1BTSHRSMN1; SMN2
SCHEMBL9637473 0.75 ADAMTS4 (0.38) ALDH1A1TSHRLMNASMN1; SMN2
SCHEMBL8644889 0.74 TDP1 (0.48) ALDH1A1CYP3A4TSHRLMNAHSD17B10
SCHEMBL7802308 0.73 KDM1A (0.39)
SCHEMBL700215 0.73 TDP1 (0.44) ALDH1A1CYP3A4TSHRLMNAHSD17B10
SCHEMBL11420002 0.73 ALDH1A1 (0.33) ALDH1A1MTNR1AMTNR1BTSHRHSD17B10
SCHEMBL2531725 0.72 HPGD (0.45) ALDH1A1TSHRLMNAHDAC1HDAC2
SCHEMBL7568907 0.72 ELANE (0.45) ALDH1A1TSHRLMNAGAASMN1; SMN2
SCHEMBL27485301 0.71 TDP1 (0.43) ALDH1A1CYP3A4TSHRLMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1234007-A1 OLIGOMERIC METHINE DYES Clariant Finance (BVI) Limited (VG) 2002-08-28 EP disclosed
US-20010012899-A1 Oligomeric methine dyes CLARIANT FINANCE ( BVI) LIMITED 2001-08-09 US disclosed
WO-2001036543-A1 OLIGOMERIC METHINE DYES CLARIANT FINANCE (BVI) LIMITED (VG) 2001-05-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010012899-A1 Oligomeric methine dyes INMT, DDT, DDC ALDH1A1 604/4885CYP3A4 1133/4885MTNR1A 527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.